GSK Pharma Fact Sheet, GSK Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK Pharma Fact Sheet    (GLXO)


Last 2 Days: Discover India's #1 defence stock now


Here is the latest financial fact sheet of GSK Pharma. For more details, see the GSK Pharma quarterly results and GSK Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

GSK PHARMA Price History

Price Rs 1,505.5
Mkt Cap Rs m 255,032
Vol '000 2.2
P/E X 237.1
P/CF X 51.6
EPS (TTM) Rs 6.3
% ch % -0.3
No. of shares m 169.41
% ch week % -0.7
% ch 1-mth % -6.1
% ch 12-mth % 1.5
52 week H/L Rs 1,805.0/1,046.4
(As on Oct 23, 2020 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

GSK PHARMA Financials

No. of Mths
Year Ending
15
Mar-15
12
Mar-16
12
Mar-17
12
Mar-18
12
Mar-19
5-Yr Chart
Click to enlarge
GSK PHARMA EQUITY SHARE DATA
High Rs3,5503,8503,8382,7603,595 
Low Rs2,3522,9662,6372,0401,253 
Sales per share (Unadj.) Rs396.5335.1343.4339.0184.7 
Earnings per share (Unadj.) Rs55.744.439.841.426.3 
Diluted earnings per shareRs27.822.219.920.726.3 
Cash flow per share (Unadj.) Rs58.747.442.945.929.2 
Dividends per share (Unadj.) Rs62.5050.0030.0035.0020.00 
Adj. dividends per shareRs31.2525.0015.0017.5020.00 
Dividend yield (eoy) %2.11.50.91.50.8 
Book value per share (Unadj.) Rs288.6257.8236.9242.9126.3 
Adj. book value per shareRs144.3128.9118.5121.4126.3 
Shares outstanding (eoy) m84.7084.7084.7084.70169.40 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x7.410.29.47.113.1 
Avg P/E ratio x53.076.781.457.992.2 
P/CF ratio (eoy) x50.372.075.552.383.1 
Price / Book Value ratio x10.213.213.79.919.2 
Dividend payout %112.2112.675.484.576.1 
Avg Mkt Cap Rs m249,933288,643274,216203,280410,626 
No. of employees `0004.74.64.74.65.0 
Total wages/salary Rs m4,9304,4344,8305,2345,372 
Avg. sales/employee Rs Th7,211.76,154.76,192.26,215.36,306.7 
Avg. wages/employee Rs Th1,058.6961.61,028.31,132.91,083.1 
Avg. net profit/employee Rs Th1,012.7815.8717.1759.3898.0 
GSK PHARMA INCOME DATA
Net Sales Rs m33,58528,37929,08528,71531,281 
Other income Rs m1,9991,2287315451,023 
Total revenues Rs m35,58429,60729,81629,26032,304 
Gross profit Rs m6,2834,7834,1905,0596,009 
Depreciation Rs m254250263380486 
Interest Rs m00326 
Profit before tax Rs m8,0285,7614,6555,2226,540 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m-51923457178287 
Tax Rs m2,7932,0231,7441,8922,373 
Profit after tax Rs m4,7163,7613,3683,5084,454 
Gross profit margin %18.716.914.417.619.2 
Effective tax rate %34.835.137.536.236.3 
Net profit margin %14.013.311.612.214.2 
GSK PHARMA BALANCE SHEET DATA
Current assets Rs m25,87021,73716,74221,81520,061 
Current liabilities Rs m5,0025,7927,20215,99914,543 
Net working cap to sales %62.156.232.820.317.6 
Current ratio x5.23.82.31.41.4 
Inventory Days Days4168536457 
Debtors Days Days1116211914 
Net fixed assets Rs m2,4444,7778,63512,47514,343 
Share capital Rs m8478478478471,694 
"Free" reserves Rs m23,59420,98519,22219,72619,704 
Net worth Rs m24,44121,83220,06920,57321,398 
Long term debt Rs m26161062 
Total assets Rs m32,24430,54930,03839,47539,113 
Interest coverage xNMNM1,552.72,612.01,091.0 
Debt to equity ratio x00000 
Sales to assets ratio x1.00.91.00.70.8 
Return on assets %14.612.311.28.911.4 
Return on equity %19.317.216.817.120.8 
Return on capital %30.726.525.526.231.9 
Exports to sales %0.20000 
Imports to sales %12.914.9000 
Exports (fob) Rs m634000 
Imports (cif) Rs m4,3344,237000 
Fx inflow Rs m699519528564534 
Fx outflow Rs m7,6808,3207,1937,4297,091 
Net fx Rs m-6,981-7,801-6,665-6,865-6,557 
GSK PHARMA CASH FLOW
From Operations Rs m 3,409 1,389 2,344 4,728 3,994 
From Investments Rs m 1,776 4,990 3,006 -1,042 -1,433 
From Financial Activity Rs m -4,970 -6,383 -5,108 -3,066 -3,584 
Net Cashflow Rs m 215 -4 242 620 -1,023 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 0.0%
Foreign collaborators 50.7%
Indian inst/Mut Fund 10.2%
FIIs 23.8%
ADR/GDR 0.0%
Free float 15.4%
Shareholders 102,036
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Dr. Annie Besant Road, Worli, Mumbai - 400 030
E-MAIL ajay.a.nadkarni@gsk.com WEB www.gsk-india.com
TELEPHONE (022) 2495 9415 FAX (022) 2498 1526
SECTOR PHARMACEUTICALS GROUP M N C
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR Price Waterhouse & Co.
CHM: D. S. Parekh COMP SEC: A. A. Nadkarni (GM & Admin) YEAR OF INC: 1924 BSE CODE: 500660 FV (Rs): 10 DIV YIELD (%): 1.3

Read: GSK PHARMA 2018-19 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   ORCHID PHARMA  LUPIN  ELDER PHARMA  SANOFI INDIA  J.B.CHEMICALS  

Compare GSK PHARMA With:   ORCHID PHARMA  LUPIN  ELDER PHARMA  SANOFI INDIA  J.B.CHEMICALS  

Compare GSK PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  




Today's Market

Sensex Ends 127 Points Higher; Auto Stocks Witness Huge Buying(Closing)

Share markets in India continued to trade on a positive note during closing hours today and ended their session marginally higher.

Views on news

GSK PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 2.2% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, GSK PHARMA has posted a net profit of Rs 1 bn (down 2.2% YoY). Sales on the other hand came in at Rs 6 bn (down 17.7% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 398.9% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, GSK PHARMA has posted a net profit of Rs 5 bn (up 398.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

More Views on News

Most Popular

My View on ITC (Fast Profits Daily)

Oct 23, 2020

What do the charts say about ITC?

The 'Seedhi Baat, No Bakwaas' View on ITC (Profit Hunter)

Oct 12, 2020

Is ITC an investment or a speculation at current levels?

Why ITC and not HUL is my Idea of a Good Investment Right Now Views On News (Views On News)

Oct 15, 2020

Rahul Shah discusses HUL's lost decade and its implications for ITC.

Why India's Drone Revolution is a 4x Profit Opportunity (Profit Hunter)

Oct 16, 2020

My research on India's leading defence companies brought me to one major player in drone manufacturing.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GSK PHARMA

GSK PHARMA - MYLAN COMPARISON

COMPARE GSK PHARMA WITH

MARKET STATS